Disruption of post-translational modifications of histone proteins perturbs the proper pattern of gene expression and has the potential to result in diseases, such as cancer. A study implicating a new histone lysine methyltransferase in tumorigenesis further corroborates the emerging link between cancer and epigenetics.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Hamamoto, R. et al. Nature Cell Biol. 6, 731–740 (2004).
Sims, R.J., Nishioka, K. & Reinberg, D. Trends Genet. 19, 629–639 (2003).
Ng, H.H., Robert, F., Young, R.A. & Struhl, K. Mol. Cell 11, 709–719 (2003).
Wysocka, J., Myers, M.P., Laherty, C.D., Eisenman, R.N. & Herr, W. Genes Dev. 17, 896–911 (2003).
Kuzmichev, A., Nishioka, K., Erdjument-Bromage, H., Tempst, P. & Reinberg, D. Genes Dev. 16, 2893–2905 (2002).
Cao, R. et al. Science 298, 1039–1043 (2002).
Gottlieb, P.D. et al. Nature Genet. 31, 25–32 (2002).
Brand, T., Andree, B., Schneider, A., Buchberger, A. & Arnold, H.H. Mech. Dev. 64, 53–59 (1997).
Abate-Shen, C. Nature Rev. Cancer 2, 777–785 (2002).
Orlando, V. Cell 112, 599–606 (2003).
Ayton, P.M. & Cleary, M.L. Oncogene 20, 5695–5707 (2001).
Varambally, S. et al. Nature 419, 624–629 (2002).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sims, R., Reinberg, D. From chromatin to cancer: a new histone lysine methyltransferase enters the mix. Nat Cell Biol 6, 685–687 (2004). https://doi.org/10.1038/ncb0804-685
Issue Date:
DOI: https://doi.org/10.1038/ncb0804-685
This article is cited by
-
Analysis of SET and MYND Domain-Containing Protein 3 (SMYD3) Expression in Gallbladder Cancer: a Pilot Study
Indian Journal of Surgical Oncology (2021)
-
Histone methylase MLL1 has critical roles in tumor growth and angiogenesis and its knockdown suppresses tumor growth in vivo
Oncogene (2013)
-
Effects of SMYD3 over-expression on cell cycle acceleration and cell proliferation in MDA-MB-231 human breast cancer cells
Medical Oncology (2011)
-
Identification and characterization of Smyd2: a split SET/MYND domain-containing histone H3 lysine 36-specific methyltransferase that interacts with the Sin3 histone deacetylase complex
Molecular Cancer (2006)